| Product ID | 83021-750_eac771e2-4c1c-3808-e053-2995a90ac5fc |
| NDC | 83021-750 |
| Product Type | Human Otc Drug |
| Proprietary Name | ANUBISMED |
| Generic Name | Ha Hyaluronic |
| Dosage Form | Cream |
| Route of Administration | TOPICAL |
| Marketing Start Date | 2022-10-17 |
| Marketing Category | OTC MONOGRAPH FINAL / |
| Application Number | M016 |
| Labeler Name | ANUBIS COSMETICS SL |
| Substance Name | 1,2-HEXANEDIOL; ALLANTOIN; ALOE VERA LEAF; BUTYLATED HYDROXYTOLUENE; C12-20 ACID PEG-8 ESTER; CAPRYLYL GLYCOL; CARBOMER HOMOPOLYMER, UNSPECIFIED TYPE; CETEARYL ETHYLHEXANOATE; CETYL ALCOHOL; DECYL OLEATE; DIMETHICONE; FRAGRANCE 13576; GLYCERIN; GLYCERYL MONOSTEARATE; GLYCERYL STEARATE SE; IMIDUREA; MEDIUM-CHAIN TRIGLYCERIDES; OCTINOXATE; OXYBENZONE; PROPYLENE GLYCOL; TOCOPHEROL; TROLAMINE; TROPOLONE; WATER |
| Active Ingredient Strength | 0 g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; mL/50mL |
| Pharm Classes | Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC], Skin Barrier Activity [PE], Standardized Chemical Allergen [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |